Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 17, Issue 4, Pages 280-299
Publisher
Springer Nature
Online
2017-12-08
DOI
10.1038/nrd.2017.221
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Arbaclofen in fragile X syndrome: results of phase 3 trials
- (2017) Elizabeth Berry-Kravis et al. Journal of Neurodevelopmental Disorders
- Acamprosate in a mouse model of fragile X syndrome: modulation of spontaneous cortical activity, ERK1/2 activation, locomotor behavior, and anxiety
- (2017) Tori L. Schaefer et al. Journal of Neurodevelopmental Disorders
- A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome
- (2017) Andrew Ligsay et al. Journal of Neurodevelopmental Disorders
- Metformin ameliorates core deficits in a mouse model of fragile X syndrome
- (2017) Ilse Gantois et al. NATURE MEDICINE
- Certainty of genuine treatment increases drug responses among intellectually disabled patients
- (2017) Karin B. Jensen et al. NEUROLOGY
- Challenges and Promises of Pediatric Psychopharmacology
- (2016) Lisa L. Giles et al. Academic Pediatrics
- Pharmacotherapy for Fragile X Syndrome: Progress to Date
- (2016) Matthew H. Davenport et al. DRUGS
- N-of-1 trials are a tapestry of heterogeneity
- (2016) Salima Punja et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome
- (2016) Laura Greiss Hess et al. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
- The NIH Toolbox Cognitive Battery for intellectual disabilities: three preliminary studies and future directions
- (2016) David Hessl et al. Journal of Neurodevelopmental Disorders
- Synaptic AMPA receptor composition in development, plasticity and disease
- (2016) Jeremy M. Henley et al. NATURE REVIEWS NEUROSCIENCE
- Impaired cognitive discrimination and discoordination of coupled theta–gamma oscillations in Fmr1 knockout mice
- (2016) Basma Radwan et al. NEUROBIOLOGY OF DISEASE
- Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials
- (2016) Elizabeth Berry-Kravis et al. Science Translational Medicine
- Reduced habituation of auditory evoked potentials indicate cortical hyper-excitability in Fragile X Syndrome
- (2016) L E Ethridge et al. Translational Psychiatry
- Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model
- (2016) Maria Gomis-González et al. Genes
- A Novel Analog Reasoning Paradigm: New Insights in Intellectually Disabled Patients
- (2016) Aurore Curie et al. PLoS One
- The GABAAreceptor is an FMRP target with therapeutic potential in fragile X syndrome
- (2015) Sien Braat et al. CELL CYCLE
- Metabotropic glutamate receptor 5 as drug target for Fragile X syndrome
- (2015) Sebastian H Scharf et al. CURRENT OPINION IN PHARMACOLOGY
- R-Baclofen Reverses a Social Behavior Deficit and Elevated Protein Synthesis in a Mouse Model of Fragile X Syndrome
- (2015) Mei Qin et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model
- (2015) Sara Silva-Santos et al. JOURNAL OF CLINICAL INVESTIGATION
- Convergence of Hippocampal Pathophysiology in Syngap+/- and Fmr1-/y Mice
- (2015) S. A. Barnes et al. JOURNAL OF NEUROSCIENCE
- Long-Term Outcomes of Early Intervention in 6-Year-Old Children With Autism Spectrum Disorder
- (2015) Annette Estes et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Fragile X mice have robust mGluR5-dependent alterations of social behaviour in the Automated Tube Test
- (2015) C.E.F. de Esch et al. NEUROBIOLOGY OF DISEASE
- 7, 8-Dihydroxyflavone induces synapse expression of AMPA GluA1 and ameliorates cognitive and spine abnormalities in a mouse model of fragile X syndrome
- (2015) Mi Tian et al. NEUROPHARMACOLOGY
- Targeting Translation Control with p70 S6 Kinase 1 Inhibitors to Reverse Phenotypes in Fragile X Syndrome Mice
- (2015) Aditi Bhattacharya et al. NEUROPSYCHOPHARMACOLOGY
- GABAB Receptor Agonist R-Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of Autism
- (2015) J L Silverman et al. NEUROPSYCHOPHARMACOLOGY
- Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back
- (2015) Christina Gross et al. Neurotherapeutics
- Increased Expression of the PI3K Enhancer PIKE Mediates Deficits in Synaptic Plasticity and Behavior in Fragile X Syndrome
- (2015) Christina Gross et al. Cell Reports
- Treatment of Cognitive Deficits in Genetic Disorders
- (2015) Thijs van der Vaart et al. JAMA Neurology
- Placebo Responses in Genetically Determined Intellectual Disability: A Meta-Analysis
- (2015) Aurore Curie et al. PLoS One
- AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: Identification, SAR and pharmacological characterization
- (2014) Ivo Vranesic et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Reversal of activity-mediated spine dynamics and learning impairment in a mouse model of Fragile X syndrome
- (2014) Bernadett Boda et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Genetic Removal of Matrix Metalloproteinase 9 Rescues the Symptoms of Fragile X Syndrome in a Mouse Model
- (2014) H. Sidhu et al. JOURNAL OF NEUROSCIENCE
- Point mutation frequency in the FMR1 gene as revealed by fragile X syndrome screening
- (2014) Maximilian Handt et al. MOLECULAR AND CELLULAR PROBES
- The contribution of de novo coding mutations to autism spectrum disorder
- (2014) Ivan Iossifov et al. NATURE
- Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
- (2014) David Cook et al. NATURE REVIEWS DRUG DISCOVERY
- Rescue of fragile X syndrome phenotypes in Fmr1KO mice by a BKCa channel opener molecule
- (2014) Betty Hébert et al. Orphanet Journal of Rare Diseases
- Longitudinal Profiles of Adaptive Behavior in Fragile X Syndrome
- (2014) C. Klaiman et al. PEDIATRICS
- Chronic Metabotropic Glutamate Receptor 5 Inhibition Corrects Local Alterations of Brain Activity and Improves Cognitive Performance in Fragile X Mice
- (2013) Aubin Michalon et al. BIOLOGICAL PSYCHIATRY
- Development of an Expressive Language Sampling Procedure in Fragile X Syndrome
- (2013) Elizabeth Berry-Kravis et al. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
- A Randomized Double-Blind, Placebo-Controlled Trial of Minocycline in Children and Adolescents with Fragile X Syndrome
- (2013) Mary Jacena S. Leigh et al. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
- Targeting the endocannabinoid system in the treatment of fragile X syndrome
- (2013) Arnau Busquets-Garcia et al. NATURE MEDICINE
- Genetic and acute CPEB1 depletion ameliorate fragile X pathophysiology
- (2013) Tsuyoshi Udagawa et al. NATURE MEDICINE
- Lovastatin Corrects Excess Protein Synthesis and Prevents Epileptogenesis in a Mouse Model of Fragile X Syndrome
- (2013) Emily K. Osterweil et al. NEURON
- Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486
- (2013) B. M. Dolan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome
- (2013) Craig A. Erickson et al. PSYCHOPHARMACOLOGY
- Chronic administration of AFQ056/Mavoglurant restores social behaviour in Fmr1 knockout mice
- (2012) Ilse Gantois et al. BEHAVIOURAL BRAIN RESEARCH
- Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model
- (2012) S. M. Goebel-Goody et al. GENES BRAIN AND BEHAVIOR
- Effectiveness and Safety of Donepezil in Boys With Fragile X Syndrome
- (2012) Jitendra Kumar Sahu et al. JOURNAL OF CHILD NEUROLOGY
- Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS)
- (2012) Andrew Knox et al. Journal of Neurodevelopmental Disorders
- Regulation of neuronal GABAB receptor functions by subunit composition
- (2012) Martin Gassmann et al. NATURE REVIEWS NEUROSCIENCE
- Genetic Removal of p70 S6 Kinase 1 Corrects Molecular, Synaptic, and Behavioral Phenotypes in Fragile X Syndrome Mice
- (2012) Aditi Bhattacharya et al. NEURON
- Chronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice
- (2012) Aubin Michalon et al. NEURON
- Medications for Adolescents and Young Adults With Autism Spectrum Disorders: A Systematic Review
- (2012) D. Dove et al. PEDIATRICS
- Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model
- (2012) M. J. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant
- (2012) Andreea S. Pop et al. PSYCHOPHARMACOLOGY
- Reversal of Disease-Related Pathologies in the Fragile X Mouse Model by Selective Activation of GABAB Receptors with Arbaclofen
- (2012) C. Henderson et al. Science Translational Medicine
- Effects of STX209 (Arbaclofen) on Neurobehavioral Function in Children and Adults with Fragile X Syndrome: A Randomized, Controlled, Phase 2 Trial
- (2012) E. M. Berry-Kravis et al. Science Translational Medicine
- Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome
- (2011) Alexia M. Thomas et al. BEHAVIOURAL BRAIN RESEARCH
- FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
- (2011) Jennifer C. Darnell et al. CELL
- N-of-1 Trials in the Medical Literature
- (2011) Nicole B. Gabler et al. MEDICAL CARE
- The productivity crisis in pharmaceutical R&D
- (2011) Fabio Pammolli et al. NATURE REVIEWS DRUG DISCOVERY
- Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome
- (2011) Zhong-Hua Liu et al. NEUROBIOLOGY OF DISEASE
- New translational assays for preclinical modelling of cognition in schizophrenia: The touchscreen testing method for mice and rats
- (2011) T.J. Bussey et al. NEUROPHARMACOLOGY
- Reversal of Fragile X Phenotypes by Manipulation of AβPP/Aβ Levels in Fmr1KO Mice
- (2011) Cara J. Westmark et al. PLoS One
- Epigenetic Modification of the FMR1 Gene in Fragile X Syndrome Is Associated with Differential Response to the mGluR5 Antagonist AFQ056
- (2011) S. Jacquemont et al. Science Translational Medicine
- Open-label add-on treatment trial of minocycline in fragile X syndrome
- (2010) Carlo Paribello et al. BMC Neurology
- Loss of the Fragile X Mental Retardation Protein Decouples Metabotropic Glutamate Receptor Dependent Priming of Long-Term Potentiation From Protein Synthesis
- (2010) Benjamin D. Auerbach et al. JOURNAL OF NEUROPHYSIOLOGY
- Excess Phosphoinositide 3-Kinase Subunit Synthesis and Activity as a Novel Therapeutic Target in Fragile X Syndrome
- (2010) C. Gross et al. JOURNAL OF NEUROSCIENCE
- Hypersensitivity to mGluR5 and ERK1/2 Leads to Excessive Protein Synthesis in the Hippocampus of a Mouse Model of Fragile X Syndrome
- (2010) E. K. Osterweil et al. JOURNAL OF NEUROSCIENCE
- Physiological Activation of Synaptic Rac>PAK (p-21 Activated Kinase) Signaling Is Defective in a Mouse Model of Fragile X Syndrome
- (2010) L. Y. Chen et al. JOURNAL OF NEUROSCIENCE
- Aripiprazole in autism spectrum disorders and fragile X syndrome
- (2010) Craig A. Erickson et al. Neurotherapeutics
- Fragile X: Leading the way for targeted treatments in autism
- (2010) Lulu W. Wang et al. Neurotherapeutics
- Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders
- (2010) Chi-Tso Chiu et al. PHARMACOLOGY & THERAPEUTICS
- Cholinergic dysfunction in fragile X syndrome and potential intervention: A preliminary1H MRS study
- (2009) Shelli R. Kesler et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of Fragile X syndrome
- (2009) Christopher J. Yuskaitis et al. BIOCHEMICAL PHARMACOLOGY
- A pilot open label, single dose trial of fenobam in adults with fragile X syndrome
- (2009) E Berry-Kravis et al. JOURNAL OF MEDICAL GENETICS
- Randomized, Controlled Trial of an Intervention for Toddlers With Autism: The Early Start Denver Model
- (2009) G. Dawson et al. PEDIATRICS
- Endocannabinoid-Mediated Control of Synaptic Transmission
- (2009) Masanobu Kano et al. PHYSIOLOGICAL REVIEWS
- Acamprosate: Recent Findings and Future Research Directions
- (2008) Karl Mann et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Design, power, and interpretation of studies in the standard murine model of ALS
- (2008) Sean Scott et al. Amyotrophic Lateral Sclerosis
- Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor/ataxia syndrome (FXTAS)
- (2008) Charlotte D'Hulst et al. BRAIN RESEARCH
- S6K1 Phosphorylates and Regulates Fragile X Mental Retardation Protein (FMRP) with the Neuronal Protein Synthesis-dependent Mammalian Target of Rapamycin (mTOR) Signaling Cascade
- (2008) Usha Narayanan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cognitive Effects of Risperidone in Children with Autism and Irritable Behavior
- (2008) Michael G. Aman et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Open-Label Treatment Trial of Lithium to Target the Underlying Defect in Fragile X Syndrome
- (2008) Elizabeth Berry-Kravis et al. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
- A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome
- (2008) David Hessl et al. Journal of Neurodevelopmental Disorders
- The touchscreen cognitive testing method for rodents: How to get the best out of your rat
- (2008) T. J. Bussey et al. LEARNING & MEMORY
- Reversal of learning deficits in a Tsc2 +/− mouse model of tuberous sclerosis
- (2008) Dan Ehninger et al. NATURE MEDICINE
- Advances in the Treatment of Fragile X Syndrome
- (2008) R. J. Hagerman et al. PEDIATRICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started